Managed care
Southern California Permanente Medical Group
Southern California Permanente Medical Group was paid $27.51M by Medicaid between Jan 2018 and Dec 2024, across 289 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 27% of everything it billed.
33Billing provider infoSOUTHERN CALIFORNIA PERMANENTE MEDICAL GROUP
BALDWIN PARK, CA 91706
BALDWIN PARK, CA 91706
33aNPI1770515280assigned 07/07/2006
33bProvider typeHealth Maintenance Organization
28Total paid$27.51M
24GClaims1,043,571
24DCodes billed289
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Health Maintenance Organization providers in California
Rank by total paid#9 of 151
Median peer was paid$59K
This provider vs. median466×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official DAVIDOFF, RAMIN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 119,065 | $243K | |
| 2019 | 146,271 | $524K | |
| 2020 | 98,510 | $2.05M | |
| 2021 | 134,127 | $3.81M | |
| 2022 | 148,433 | $4.60M | |
| 2023 | 177,703 | $6.76M | |
| 2024incomplete | 219,462 | $9.53M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 91,509 | 88,443 | $7.35M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 12% | 35,285 | 34,966 | $3.25M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 5.7% | 104,815 | 101,688 | $1.57M |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 3.9% | 23,164 | 22,671 | $1.08M |
| 92227 | 3.2% | 83,187 | 83,020 | $877K | |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 3.1% | 19,861 | 19,713 | $852K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.9% | 17,289 | 14,006 | $808K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.7% | 4,552 | 3,033 | $756K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 2.3% | 103,348 | 103,002 | $644K |
| 90662 | 2.2% | 5,579 | 5,541 | $603K | |
| 67028 | Intravitreal injection of a pharmacologic agent | 1.8% | 2,345 | 2,302 | $490K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.6% | 15,594 | 10,281 | $438K |
277 more codes
| 99285 | Emergency room visit (most serious) | 1.6% | 3,472 | $429K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.4% | 6,748 | $385K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1.3% | 41,506 | $354K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.1% | 19,728 | $307K |
| 92015 | Determination of refractive state | 1.0% | 34,031 | $289K |
| 92002 | <1% | 7,753 | $267K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 3,158 | $265K |
| 99442 | <1% | 3,276 | $234K | |
| 97597 | <1% | 1,841 | $232K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 3,014 | $227K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 3,007 | $223K |
| 0002A | <1% | 5,656 | $218K | |
| 0001A | <1% | 5,561 | $211K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 7,096 | $202K |
| 90686 | <1% | 44,037 | $183K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 18,858 | $163K |
| 20610 | <1% | 1,451 | $162K | |
| 92557 | <1% | 2,692 | $144K | |
| 92134 | <1% | 5,967 | $138K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 4,693 | $130K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 1,491 | $128K |
| 71045 | Radiologic examination, chest; single view | <1% | 19,275 | $127K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,483 | $126K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,761 | $122K |
| 0064A | <1% | 2,884 | $116K | |
| 0124A | <1% | 3,286 | $111K | |
| 99443 | <1% | 1,067 | $111K | |
| 0004A | <1% | 2,283 | $90K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 3,241 | $89K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 4,867 | $88K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 4,438 | $87K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 3,607 | $85K |
| 93880 | <1% | 218 | $82K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 7,042 | $81K |
| 90674 | <1% | 6,352 | $79K | |
| 77080 | <1% | 2,508 | $79K | |
| 92567 | <1% | 4,514 | $79K | |
| J7999 | Compounded drug, not otherwise classified | <1% | 1,204 | $77K |
| 0054A | <1% | 1,722 | $71K | |
| 92551 | <1% | 25,394 | $70K | |
| 91320 | <1% | 355 | $69K | |
| 0012A | <1% | 1,835 | $69K | |
| 73030 | <1% | 3,448 | $66K | |
| 90837 | Psychotherapy session, about an hour | <1% | 1,619 | $65K |
| 93922 | <1% | 389 | $63K | |
| 0071A | <1% | 1,576 | $63K | |
| 73562 | <1% | 3,267 | $61K | |
| 0134A | <1% | 1,638 | $59K | |
| 93970 | <1% | 200 | $59K | |
| J0248 | Injection, remdesivir, 1 mg | <1% | 58 | $59K |
| 0011A | <1% | 1,635 | $59K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 365 | $58K |
| 00142 | <1% | 91 | $58K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 2,525 | $55K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 3,271 | $52K |
| 0072A | <1% | 1,238 | $49K | |
| 72100 | <1% | 2,475 | $48K | |
| 90750 | <1% | 535 | $46K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 2,570 | $43K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 493 | $41K |
| 76830 | Ultrasound, transvaginal | <1% | 2,111 | $38K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 15,899 | $37K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 14,961 | $35K |
| 99441 | <1% | 1,068 | $35K | |
| 73630 | <1% | 3,249 | $34K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 529 | $29K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 216 | $27K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 1,287 | $27K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 952 | $26K |
| 93990 | <1% | 76 | $26K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 1,650 | $25K |
| 90480 | <1% | 424 | $25K | |
| 90656 | <1% | 4,448 | $22K | |
| 0154A | <1% | 495 | $19K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 267 | $19K |
| 92523 | <1% | 572 | $18K | |
| 90677 | <1% | 474 | $16K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 555 | $16K |
| 73610 | <1% | 1,480 | $15K | |
| 73130 | <1% | 977 | $15K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 968 | $15K |
| 90734 | <1% | 374 | $15K | |
| 97161 | <1% | 155 | $14K | |
| 90651 | <1% | 682 | $14K | |
| 90670 | <1% | 1,080 | $14K | |
| 76801 | <1% | 273 | $13K | |
| 99223 | Prolong inpt eval add15 m | <1% | 76 | $13K |
| 0031A | <1% | 310 | $12K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 248 | $12K |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | <1% | 25 | $11K |
| 90694 | <1% | 98 | $11K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 1,398 | $10K |
| 31231 | <1% | 54 | $10K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 122 | $10K |
| 77065 | Tomosynthesis, mammo | <1% | 262 | $10K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 53 | $10K |
| 76536 | <1% | 268 | $9K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 8,249 | $9K |
| 76813 | <1% | 363 | $9K | |
| 73502 | <1% | 159 | $9K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 80 | $9K |
| 88341 | <1% | 84 | $8K | |
| 76770 | <1% | 369 | $8K | |
| 74183 | <1% | 28 | $8K | |
| 96116 | <1% | 481 | $8K | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 21,737 | $7K |
| 99173 | <1% | 14,903 | $7K | |
| 72050 | <1% | 186 | $7K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 137 | $7K |
| 62322 | <1% | 28 | $6K | |
| 0074A | <1% | 173 | $6K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 266 | $6K |
| 90678 | <1% | 33 | $6K | |
| 88342 | <1% | 190 | $6K | |
| 74018 | <1% | 703 | $6K | |
| 83520 | <1% | 248 | $6K | |
| 0081A | <1% | 137 | $5K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 952 | $5K |
| 0082A | <1% | 132 | $5K | |
| 99417 | Prolong home eval add 15m | <1% | 302 | $5K |
| 81329 | <1% | 202 | $5K | |
| 99177 | <1% | 3,816 | $5K | |
| 88304 | <1% | 693 | $4K | |
| 0051A | <1% | 108 | $4K | |
| 0052A | <1% | 101 | $4K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 532 | $4K |
| 73564 | <1% | 123 | $4K | |
| 76641 | <1% | 173 | $4K | |
| 93926 | <1% | 12 | $4K | |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or qualified healthcare professional, with or without direct patient contact (list separately in addition to cpt codes 99205, 99215, 99483 for office or other outpatient evaluation and management services) (do not report g2212 on the same date of service as 99358, 99359, 99415, 99416). (do not report g2212 for any time unit less than 15 minutes) | <1% | 51 | $4K |
| 93294 | <1% | 41 | $4K | |
| 0112A | <1% | 96 | $4K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 940 | $4K |
| 99205 | Prolong outpt/office vis | <1% | 24 | $4K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | <1% | 82 | $3K |
| 0013A | <1% | 78 | $3K | |
| 93296 | <1% | 41 | $3K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 427 | $3K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 100 | $3K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 59 | $3K |
| 90648 | <1% | 1,534 | $3K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 141 | $2K |
| 0003A | <1% | 60 | $2K | |
| 90723 | <1% | 483 | $2K | |
| 72141 | <1% | 29 | $2K | |
| 91200 | <1% | 64 | $2K | |
| 74170 | <1% | 12 | $2K | |
| 0111A | <1% | 52 | $2K | |
| 62323 | <1% | 13 | $2K | |
| 11900 | <1% | 69 | $2K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 24 | $2K |
| 82105 | <1% | 352 | $2K | |
| 99221 | <1% | 27 | $2K | |
| 99234 | <1% | 13 | $2K | |
| 99100 | <1% | 26 | $2K | |
| 97165 | <1% | 65 | $1K | |
| 71250 | <1% | 12 | $1K | |
| 95117 | <1% | 126 | $1K | |
| 90715 | <1% | 109 | $1K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 26 | $1K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 133 | $1K |
| 92250 | <1% | 102 | $1K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 134 | $1K |
| 76642 | <1% | 38 | $1K | |
| 87338 | <1% | 627 | $1K | |
| 90672 | <1% | 503 | $1K | |
| 90660 | <1% | 215 | $1K | |
| 94060 | <1% | 64 | $1K | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 28 | $1K |
| 73140 | <1% | 232 | $986.10 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 494 | $946.86 |
| 73100 | <1% | 66 | $942.50 | |
| 78306 | <1% | 13 | $819.03 | |
| 97010 | <1% | 133 | $743.00 | |
| 87799 | <1% | 14 | $725.92 | |
| 17110 | <1% | 25 | $674.00 | |
| 72040 | <1% | 37 | $637.26 | |
| 98968 | <1% | 14 | $600.00 | |
| 92579 | <1% | 24 | $547.00 | |
| 76706 | <1% | 12 | $520.00 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 58 | $515.00 |
| 90633 | <1% | 263 | $510.00 | |
| 81002 | <1% | 332 | $436.36 | |
| 99051 | <1% | 25,745 | $430.93 | |
| 0034A | <1% | 12 | $421.96 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 37 | $417.41 |
| 92133 | <1% | 18 | $417.00 | |
| 97035 | <1% | 41 | $416.00 | |
| 90655 | <1% | 194 | $392.00 | |
| 82962 | <1% | 157 | $375.31 | |
| 99188 | <1% | 119 | $346.00 | |
| 0083A | <1% | 101 | $314.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 156 | $300.00 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 232 | $239.15 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 13 | $235.16 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 427 | $233.68 |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 14 | $217.63 |
| 51798 | <1% | 14 | $204.00 | |
| 99460 | <1% | 131 | $179.21 | |
| 86800 | <1% | 13 | $158.95 | |
| 73110 | <1% | 30 | $156.84 | |
| 73560 | <1% | 26 | $135.00 | |
| 81025 | <1% | 72 | $111.00 | |
| 90716 | <1% | 12 | $108.00 | |
| 90707 | <1% | 12 | $74.00 | |
| 0173A | <1% | 15 | $44.75 | |
| 90658 | <1% | 269 | $40.21 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 57 | $35.05 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,042 | $34.16 |
| 99307 | <1% | 111 | $33.96 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 56 | $31.17 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 56 | $31.07 |
| 80061 | Lipid panel | <1% | 546 | $23.08 |
| 73590 | <1% | 35 | $20.69 | |
| 82570 | <1% | 14 | $19.00 | |
| 80051 | <1% | 562 | $18.72 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 419 | $14.76 |
| 84403 | <1% | 39 | $10.08 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 21 | $9.60 |
| 84460 | <1% | 479 | $9.16 | |
| 82565 | <1% | 841 | $8.62 | |
| 82947 | <1% | 161 | $6.60 | |
| 85027 | <1% | 125 | $5.71 | |
| 82310 | <1% | 144 | $4.10 | |
| 84520 | <1% | 149 | $3.15 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 12 | $3.04 |
| G9920 | Screening performed and negative | <1% | 6,544 | $0.19 |
| 1036F | 0% | 18,618 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 113 | $0.00 |
| 90696 | 0% | 12 | $0.00 | |
| 83550 | 0% | 66 | $0.00 | |
| 93018 | 0% | 55 | $0.00 | |
| 87081 | 0% | 12 | $0.00 | |
| 85652 | 0% | 12 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 146 | $0.00 |
| 99024 | 0% | 70 | $0.00 | |
| 84153 | 0% | 57 | $0.00 | |
| 82043 | 0% | 351 | $0.00 | |
| 82670 | 0% | 28 | $0.00 | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 0% | 82 | $0.00 |
| 84075 | 0% | 79 | $0.00 | |
| 3044F | 0% | 888 | $0.00 | |
| 82040 | 0% | 80 | $0.00 | |
| 82728 | 0% | 79 | $0.00 | |
| 52000 | 0% | 13 | $0.00 | |
| 83002 | 0% | 25 | $0.00 | |
| 83921 | 0% | 15 | $0.00 | |
| 82607 | 0% | 113 | $0.00 | |
| 83735 | 0% | 28 | $0.00 | |
| 86780 | 0% | 15 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 30 | $0.00 |
| 84132 | 0% | 84 | $0.00 | |
| 87088 | 0% | 315 | $0.00 | |
| 82746 | 0% | 18 | $0.00 | |
| 96112 | 0% | 12 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 12 | $0.00 |
| 84439 | 0% | 133 | $0.00 | |
| 99201 | 0% | 81 | $0.00 | |
| 85610 | 0% | 80 | $0.00 | |
| 83721 | 0% | 31 | $0.00 | |
| 3046F | 0% | 91 | $0.00 | |
| 83540 | 0% | 82 | $0.00 | |
| 90661 | 0% | 743 | $0.00 | |
| 99354 | 0% | 15 | $0.00 | |
| 84165 | 0% | 12 | $0.00 | |
| 81003 | 0% | 67 | $0.00 | |
| 83970 | 0% | 40 | $0.00 | |
| 84450 | 0% | 63 | $0.00 | |
| 82247 | 0% | 86 | $0.00 | |
| 87186 | 0% | 74 | $0.00 | |
| 84100 | 0% | 29 | $0.00 | |
| 84295 | 0% | 28 | $0.00 | |
| 82274 | 0% | 226 | $0.00 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 77 | $0.00 |
| 92081 | 0% | 22 | $0.00 | |
| 90791 | Psychiatric diagnostic evaluation | 0% | 12 | $0.00 |
| 90710 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAVIDOFF, RAMIN (EXECUTIVE MEDICAL DIRECTOR)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.